The Global Polio Laboratory Network maintains active surveillance for circulating live polioviruses by obtaining and testing stool samples from patients with acute flaccid paralysis. However, most poliovirus infections occur with no symptoms, and questions remain about the probability of undetected wild poliovirus (WPV) circulation after the apparent interruption of WPV transmission in different populations. In the context of making decisions about the timing of oral poliovirus vaccine cessation following global eradication of WPV, policy-makers need an understanding of this probability as a function of time. Prior modeling of the probability of undetected circulation relied on relatively simple models and assumptions, which limits extrapolation to current conditions. In this analysis, the authors revisit the topic and highlight important considerations for policy-makers related to the impact of initial conditions and seasonality and emphasize the need to focus on appropriate characterization of conditions in the last likely reservoirs of the virus. The authors conclude that the probability of undetected WPV circulation may vary significantly for different poliovirus serotypes, places, and conditions, which suggests that achieving the same level of confidence about the true interruption of WPV transmission will require different periods of time for different situations.
As the Global Polio Eradication Initiative drives the number of paralytic poliomyelitis cases caused by wild polioviruses (WPVs) toward zero, questions arise about the possibility of undetected or silent circulation of infection, particularly since most poliovirus infections occur asymptomatically. The last case of WPV type 2 occurred in northern India in 1999, and ongoing, active surveillance for cases of acute flaccid paralysis reveals no evidence of undetected transmission or reemergence. Circulation of all WPVs has been successfully stopped in 3 of the 6 World Health Organization regions, and endemic circulation of WPV types 1 and 3 continues in shrinking geographic areas that export WPV and cause outbreaks. Typical estimates suggest that permanent paralytic poliomyelitis occurs at a rate of approximately 1 case per 200 infections, on average, in immunologically naive (i.e., fully susceptible) individuals, although the rates differ by serotype (1) (2) (3) .
Two different polio vaccines provide effective protection from paralytic poliomyelitis, which adds to the complexity of modeling the transmission of poliovirus infections and population immunity (4) . Inactivated poliovirus vaccine (IPV) provides direct systemic immunity to vaccine recipients but requires an injection, comes at a comparatively higher cost, and does not provide significant enteric mucosal immunity to prevent participation in fecal-oral transmission (4) (5) (6) . The easier-to-administer and less expensive oral poliovirus vaccine (OPV) contains a live attenuated virus that infects the vaccine recipient and induces both mucosal and systemic immunity, and OPV infections can spread to others, providing secondary immunity (2, 4, 6) . However, OPV can cause sporadic cases of vaccine-associated paralytic poliomyelitis in vaccine recipients or their contacts (approximately 1 in 2.5 million doses in developed countries) (7) (8) (9) (10) , and it may lead to outbreaks of vaccine-derived poliovirus infection (11) (12) (13) (14) (15) . Ultimately, eradicating all poliomyelitis cases will require OPV cessation and stopping all transmission of vaccine-derived polioviruses (16) (17) (18) (19) (20) (21) . Coordinated OPV cessation should occur only after assurance that WPV has stopped circulating everywhere (22, 23) .
Surveillance conducted by the Global Polio Laboratory Network and vaccination response following detection of outbreaks represent critical components of the Global Polio Eradication Initiative (16-18, 24, 25) . The surveillance system targets the collection of 2 stool samples from patients with acute flaccid paralysis, recognized as paralysis characterized by rapid progression of loss of muscle tone or weak, floppy (i.e., not spastic or rigid) muscle with loss of voluntary movement. Cases of acute flaccid paralysis occur from nonpoliovirus causes in approximately 1 per 100,000 children younger than 15 years of age, and the Global Polio Laboratory Network confirms a poliomyelitis case following WPV isolation (24, 25) . The surveillance system performs well, as demonstrated by the robustness of its results, which have supported certification of 3 World Health Organization regions as free of indigenous WPVs (26) (27) (28) and the absence of any subsequent reported indigenous WPVs in these regions. The World Health Organization used the experience of the Pan American Health Organization as a basis for requiring a period of at least 3 years of no paralytic polio cases detected by acute flaccid paralysis surveillance for certification (23) . Debanne and Rowland (29) reported less than a 5% chance of undetected indigenous WPV circulation after 4 years since the last reported confirmed case, based on their statistical analysis of Pan American Health Organization data. However, regions and areas within them differ, and indigenous WPV strains reemerged after years of no detected clinical cases in a few places that failed to stop transmission and experienced some significant surveillance gaps (30, 31) .
Eichner and Dietz (32) characterized the probability of undetected poliovirus circulation using a relatively simple dynamic and stochastic infection transmission model of a hypothetical, homogeneously mixed population of 200,000 people in a relatively low-income country that grows exponentially at a constant annual rate (a) (e.g., 2% growth in the base case). In related deterministic, dynamic transmission models, Eichner and Hadeler (33) population, and Eichner et al. (34) explored issues related to characterizing the minimum population size required for poliovirus persistence. Eichner and Dietz (32) initialized their simulation at the WPV endemic equilibrium, at which point they started vaccination of newborns according to an effective vaccination coverage percentage (p). They estimated the probability of extinction (POE) in the population by counting the number of iterations that led to the disruption of transmission (i.e., zero prevalence of WPV-infected individuals in the population) and dividing this by the total number of iterations in the simulation. Extinction does not occur in all iterations in a simulation, and the POE depends on the selected model input values.
Eichner and Dietz (32) assumed that a case occurred at time 0, used a time horizon of 10 years, and recorded the time since the last paralytic case on a monthly basis (i.e., 120 simulated month observations), which they called a case-free period (CFP). They characterized the probability of WPV circulation persisting given a CFP of length t months, which they called the ''probability of silent infections,'' by dividing the number of all CFPs of length t months with WPV present by the total number of all CFPs of length t months. Intuitively, short CFPs will often occur while WPV still circulates, leading to a high fraction of CFPs with circulation, but as the CFP increases, the probability of continued WPV circulation decreases. Using these methods, Eichner and Dietz (32) reported that not observing a case for 3 years provided 95% confidence of local extinction of WPV infections in their simple hypothetical model. We use the notation CFPx% to indicate the time at which fewer than x% of the CFP values occur with WPV present, and we note that Eichner and Dietz (32) presented both CFP5% and CFP1% values, with full recognition that the selection of the level of confidence represents a policy choice.
The possibility of silent transmission continues to raise concerns about outbreaks, potential reestablishment of widespread transmission, and the level of confidence in achieving actual WPV eradication. Given renewed interest in assessing the probability of undetected WPV circulation after global WPV eradication, we reconstructed Eichner and Dietz's model (32) to explore the importance of framing choices they made about initial conditions and seasonality and discuss limitations associated with using simple models to support policy choices.
MATERIALS AND METHODS
Starting with the differential equations, notation, and input values provided by Eichner and Dietz (32), we reconstructed their OPV and IPV models in Java using the Eclipse open development platform (Eclipse Foundation, Inc., Ottawa, Ontario, Canada). Figures 1 and 2 
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representation of the OPV and IPV models, respectively. Equivalent to the set of differential equations provided by Eichner and Dietz (32) , these schematics show the assumed infection states, processes relevant for OPV ( Figure 1 ) and IPV ( Figure 2 ) vaccination, and transitions affected by the various model inputs. The models assume that incubation (i.e., the state between virus exposure and becoming infectious) and infection (i.e., the state of infectiousness to others) each occur in 2 stages, with half of the total duration assigned to each stage. The models assume that only those individuals who have no prior poliovirus infection and are not effectively vaccinated with IPV can develop paralytic poliomyelitis according to the paralysis-to-infection ratio (e.g., 1:200 for the base case). As Figures 1 and 2 show, the models further assume that individuals remain fully and permanently protected from reinfection by any poliovirus following recovery from a WPV or OPV infection. This represents a very important simplification, because individuals with prior exposure to live or inactivated polioviruses can get reinfected at any age and potentially participate in infection transmission, albeit with a lower probability of becoming infected and with shorter durations of infection and infectiousness than fully susceptible individuals (4, (35) (36) (37) (38) .
For both the OPV and IPV models, Eichner and Dietz (32) We explored the impact of model framing assumptions related to the initial conditions, seasonality, time horizon, and recording interval used in the simulation for CFPs. We explored the impact of changing the initial conditions from the WPV endemic equilibrium (32) to the equilibrium with 55% effective vaccination coverage, which required that we calculate the new equilibrium state for the population (see Appendix). We conducted the simulations starting at the new equilibrium state of vaccination with 55% coverage for both models and then increased vaccination to the effective vaccination coverage levels used by Eichner and Dietz (32) in their original 1-way sensitivity analyses. We explored the impact of seasonality by varying the basic reproduction number while maintaining a fixed average (R w ¼ 12) using 2 different approaches: 1) a sine function with amplitude of 0.5 3 average R w and the high season peaking on July 15 and 2) high and low seasons (with varied lengths) with the low season R w fixed (R w L ¼ 8) and R w H varied to keep the overall R w ¼ 12 and maintaining the high season centered in time around July 15. We found unstable results with only 1,000 iterations, so we used 50,000 iterations for all of our simulations to obtain stable results within 60.1 year.
Although it is not observable in the field, in the context of modeling we can characterize the time of silent circulation (TSC) as the time between the last case and the end of WPV infection transmission for each iteration of the simulation that ends with extinction. After performing 50,000 iterations and creating the empirical cumulative distribution function (ECDF) of all of the TSC values (n 50,000), we can estimate the time after which the probability of occurrence of a longer TSC becomes less than x% (TSCx%). Thus, the TSC5% represents the time t that satisfies the equation 1 À ECDF(t) ¼ P[TSC > t] 0.05. Although the Global Polio Laboratory Network cannot actually identify a case as the last one at the time it occurs and can only identify a case as last after having observed no cases for a long time, the TSC represents a quantity of interest because it tells us how much time we can expect to pass between the last paralytic case and actual extinction of infections. In contrast, by considering the fraction of CFPs that occur in the context of WPV circulation, the CFPx% metric addresses the probability that silent WPV circulation continues as a function of time without observed cases. Figure 3 depicts the occurrence of simulated paralytic cases (dots) as a function of time for 10 randomly selected stochastic iterations. Cases occur frequently at the beginning of the simulation and decrease in frequency over time, which makes it easy to see how CFP values near 0 months arise. Cases occur frequently just after the start of the model (i.e., when conditions begin to change from the endemic equilibrium due to the initiation of vaccination of some newborns), which leads to many CFP values of 0 months, because when checking monthly the ''case-free'' time elapsed between cases that occur in the same month or in sequential months equals 0. As the cases become less frequent, the simulation may record multiple CFP values between cases. Thus, in a given stochastic iteration, if a CFP value of 6 months gets recorded, Table continues implying at least 6 months between 2 cases or after the last case, then this must follow recorded CFP values of 5, 4, 3, 2, and 1 months. Most of the iterations in Figure 3 clearly lead to extinction of WPV, as shown by the black lines that begin at the time of the last case and end when WPV circulation stops in the model. However, several of the iterations show cases followed by a time period when WPV continues to circulate until the end of the 10-year time horizon, as shown by the dashed black lines in Figure 3 . We found that shortening the time horizon to 5 years significantly lowered the POE (i.e., from 87.6% to 40.5%) and decreased the average of the CFPs by not allowing for any CFP observations of more than 4.1 years, but we confirmed that the time horizon of 10 years used in the original analysis (32) remains sufficient. We found that changing the recording interval leads to a negligible impact (results not shown). Tables 1 and 2 show our results from repeating the 1-way sensitivity analyses reported by Eichner and Dietz (32) for vaccination with OPV and IPV, respectively, including the POE, CFP5%, CFP1%, TSC5%, and TSC1% estimates. Tables 1 and 2 include several values and model inputs not reported by Eichner and Dietz (32) that we felt provided important insights. Our base case results match the CFP5% values reported by Eichner and Dietz (32) within 0.1 years (i.e., 2.8 vs. 2.9 using OPV; 3.0 vs. 2.9 using IPV) and the POE values within 2% (i.e., 87.6% vs. 87.2% using OPV; 77.1% vs. 75.1% using IPV). The differences in our results reflect our use of the original equations presented by Eichner and Dietz (32) , which allow mortality to occur from all states shown in Figures 1 and 2 , and from the greater stability of our results given our use of 50,000 iterations for all simulations.
RESULTS
Increasing the paralysis-to-infection ratio significantly changes the length of time required to observe cases, with lower values implying the need to wait longer because cases occur less frequently. Changing the paralysis-to-infection ratio does not, however, affect the transmission of infection or the POE; it merely changes the frequency with which we can observe evidence of circulation as cases. We expanded the range to include a ratio of 1:1,000, which may represent a more appropriate paralysis-to-infection ratio for WPV type 3 (3), and the results suggested the need to potentially consider different policies for the 3 poliovirus serotypes.
We observe consistent changes in the POE values with increases in different input values. Increases in the effective Abbreviations: CFP, case-free period; OPV, oral poliovirus vaccine; POE, probability of extinction; TSC, time of silent circulation; WPV, wild poliovirus.
a CFPx %, case-free period after which the probability of WPV circulation becomes less than x %. b TSCx %, time at which the probability of silent WPV circulation after the true last case becomes less than x %.
vaccination coverage (p), the relative transmissibility of OPV compared with WPV (b), life expectancy (1/l), and the percentage of successfully IPV-vaccinated individuals who derive full protection (ã) increase the POE. In contrast, increases in population size (N), population growth rate (a), basic reproduction number (R W ), relative susceptibility for IPV-vaccinated individuals who remain partially susceptible to asymptomatic infections (c), duration of incubation period (d), and duration of infectivity (c) decrease the POE. Although we might expect that the CFPx% and TSCx% would directly track the behavior of the POE, we see from Tables 1 and 2 
:
Theoretically, using a deterministic model, for p ! 69% for OPV and p ! 98% for IPV, WPV extinction occurs with Table continues certainty (33) . However, in stochastic models, extinction can occur due to chance in some iterations for values of p < p*, and it may not occur in all iterations for p > p* within the time horizon, which implies a fuzzier concept than a fixed threshold. Nonetheless, the threshold equations provide helpful insights by showing that increasing b decreases p* OPV , which explains the nonmonotonic changes in the CFPx% and TSCx% values in Tables 1 and 2 . For values of p much greater than p*, extinction typically occurs relatively quickly in most iterations, which leads to relatively small CFPx% and TSCx% values because the high population immunity stops transmission. In contrast, when p approaches p*, we observe that circulation can continue longer, because effective vaccination coverage just over the threshold allows the number of susceptibles to build up relatively quickly, which supports sustained transmission with long delays between cases. For p values far below p*, cases occur frequently unless extinction occurs by chance following an outbreak, leading to a shorter CFPx% and only a short period of silent circulation after the last case. Although 1-way sensitivity analyses do not capture the multiway effects, investing in more extensive sensitivity analyses for this simple model did not make Abbreviations: CFP, case-free period; IPV, inactivated poliovirus vaccine; POE, probability of extinction; TSC, time of silent circulation; WPV, wild poliovirus.
a CFPx %, case-free period after which the probability of WPV circulation becomes less than x %. b TSCx %, time at which the probability of silent WPV circulation after the true last case becomes less than x %. Abbreviations: CFP, case-free period; POE, probability of extinction; TSC, time of silent circulation. a CFP5%, case-free period after which the probability of WPV circulation becomes less than 5%. b TSC5%, time at which the probability of silent WPV circulation after the true last case becomes less than 5%. sense because the model does not capture complexity that arises in real situations or the real correlations that exist between inputs. Thus, we concluded that future analyses will need to focus on appropriately characterizing the inputs relevant to the conditions in the last likely WPV reservoirs using more sophisticated models and ensure the validity of key framing assumptions. Table 3 shows the impact of changing the different initial conditions. Starting the simulation at equilibrium with 55% effective vaccination coverage instead of the endemic equilibrium decreases the POE significantly. For example, the column with OPV base case (effective vaccine coverage equal to 60%) shows that the POE drops from 87.6% to 22.6% with the change in the initial conditions, which demonstrates that the different dynamics of building up population immunity matter (39, 40) . Specifically, the greater force of infection from WPV at the endemic equilibrium compared with OPV vaccination creates a rapid drop in population immunity when vaccination starts, which leads to a greater probability of reaching zero prevalence of WPV by chance. Notably, for the OPV base case (p ¼ 60%), starting at the equilibrium with 55% effective vaccination coverage instead of the endemic equilibrium increases the CFP5% from 2.8 years to 3.3 years, with similar changes for the IPV base case. The 55% effective vaccination coverage falls far below the theoretical threshold for extinction with OPV or IPV (i.e., 69% or 98%) (33) , and introducing vaccination decreases the spread of WPV, which lengthens the time between cases (32). Consequently, observing a longer CFP provides relatively less assurance of disruption of WPV circulation when starting at the new equilibrium, which implies the need to wait longer to achieve high confidence about the actual cessation of WPV circulation.
In addition to observing a big impact from the selection of the initial conditions, we found that seasonality may also play an important role. Figure 4A shows our different assumptions about seasonality, which produce the same overall average R w . Parts B and C of Figure 4 show how the CFP5% curves shift as a function of seasonality when introducing OPV and IPV, respectively, for the base case values starting at the endemic equilibrium. Table 4 summarizes the changes in the POE, CFP5%, and TSC5%, including results with additional high-low season divisions beyond the three depicted in Figure 4 . Our analysis suggests that a short, intense high season followed by a relatively long low season (i.e., H3-L9) increases the POE, which changes from 87.6% to 100.0% using OPV (from 77.1% to 99.9% using IPV) in comparison with the base case. Longer high seasons tend to lengthen the time that WPV circulation continues after the last paralytic case, as expected due to the monotonicity between length of the high season and TSC5%.
DISCUSSION
Although the current certification criterion (23) appears reasonable in the context of the existing model results, our analyses provide additional context and raise several issues for consideration. First, serotype differences in the paralysisto-infection ratios may imply significant differences between the relevant CFP and TSC values. Second, we highlight the importance of our observation of a wide range of POE results. Concerns about silent circulation of WPVs depend on first achieving the goal of apparent WPVextinction. Some of the combinations of inputs and conditions we explored demonstrate the importance of using strategies beyond low levels of routine immunization of newborns to achieve extinction. In the context of implementing the Global Polio Eradication Initiative, much of the success with respect to achieving relatively high levels of population immunity in some countries depended on conducting supplemental immunization activities. This suggests that future modeling efforts will need to deal with a much more complex set of assumptions about the underlying population immunity and the Abbreviations: CFP, case-free period; H, high season; L, low season; POE, probability of extinction; TSC, time of silent circulation. a CFP5%, case-free period after which the probability of wild poliovirus circulation becomes less than 5%. b TSC5%, time at which the probability of silent wild poliovirus circulation after the true last case becomes less than 5%. c H3-L9 indicates 3 months of high season (H3) and 9 months of low season (L9).
actual interventions used to achieve global WPV eradication (4). Third, our results suggest that framing assumptions about the initial conditions and seasonality may represent important factors that simple sensitivity analyses focused on varying inputs will miss. The endemic equilibrium represents the starting point that provides the maximum population immunity from WPV infections. However, countries typically do not instantly increase coverage to a sufficiently high level to eradicate; instead, they gradually increase coverage. In the context of the Global Polio Eradication Initiative, countries might further increase coverage and add supplemental immunization activities to interrupt transmission (41, 42) . Our results suggest that starting at more realistic conditions with respect to population immunity may imply the need to wait longer to certify a population as polio-free in some places. We anticipate that the actual path taken to pursue WPV eradication, the policies following the last detected case, and accurate representation of the actual field conditions will influence the probability of undetected WPV circulation over time, and this implies the need to move away from reliance on simple, hypothetical models toward models of the actual conditions that exist in the last real WPV reservoirs. Our results also suggest that policy-makers need to evaluate the specific concepts modeled (CFP, TSC, and POE) and consider the information provided by complimentary metrics.
Fourth, the choice of the confidence level that policy-makers require for certification comes with real trade-offs. The risks associated with continued use of OPV create incentives to stop OPV use soon after the certification of global WPV eradication, but some uncertainty will remain about the possibility of undetected WPV circulation and about potential risks of reintroduction (unintentional or intentional). While we did not focus on the length of time that circulating vaccinederived polioviruses might silently circulate, we note that although they behave similarly to WPVs in some respects, additional modeling will need to specifically address the issue of potential silent circulating vaccine-derived poliovirus transmission in the context of any real populations of concern with appropriate consideration of the actual conditions. Several limitations in this and the prior analyses (32-34) warrant additional consideration. The models ignore the real heterogeneity that exists in the world and the actual conditions that affect the ability of poliovirus to be transmitted in populations and subgroups. In addition, while successful vaccination with either OPV or IPV probably leads to permanent immunity from paralytic poliomyelitis, vaccinated individuals can still become reinfected if challenged with a live poliovirus (6) and can participate in the transmission of infection. Individuals with only IPV-induced immunity can become infected nearly as frequently as susceptibles and can excrete as much or nearly as much virus in feces as susceptibles (5) . This implies the need to modify the model framing assumption that a fraction of IPV vaccinees become fully immune to infection and to include the effects of reinfection and waning (4, 42) . Actual effective vaccination coverage varies for an individual country as a function of time and among subgroups within the population (43) , and nonrandom, heterogeneous mixing occurs. The models also implicitly assume perfect surveillance, although surveillance quality may vary significantly, with poor-quality surveillance often coinciding with poverty, low vaccine coverage, and other conditions that favor poliovirus transmission. In future studies, investigators will need to address the impacts of imperfect surveillance quality, because lower-quality surveillance will increase the CFP and TSC, and they should also consider potential opportunities to enhance and improve surveillance, perhaps including environmental surveillance (44) .
We hope this study provides additional insights about the potential of undetected WPV circulation and that future research will address the key limitations, which should go beyond consideration of uncertainty in the model inputs and focus specifically on the complex population immunity that exists in the real populations likely to represent the last WPV reservoirs. 
